Assessment of tumor-suppressive inflammatory tendency of Echis coloratus venom against colon carcinogenesis, via up-regulation of anti-tumorigenic inflammatory cells and down-regulation of pro-tumorigenic inflammatory cells, in colon cancer cell lines

References

• Ahmad, D., et al., 2013. Epigenetic and genetic features of 24 colon cancer cell lines. Oncogenesis, 2 (9), 71.
   Google Scholar
• Al-asmari, A.K., et al., 2016. snake venom causes apoptosis by increasing the reactive oxygen species in colorectal and breast cancer cell lines. Onco targets and therapy, 9, 6485–6498.
   PubMed Web of Science ®Google Scholar
• Aoyagi, T., et al., 2014. Current treatment options for colon cancer peritoneal carcinomatosis. World journal of gastroenterology, 20 (35), 12493–12500.
   PubMed Web of Science ®Google Scholar
• Bahri, R., et al., 2015. IL-15 suppresses colitis-associated colon carcinogenesis by inducing antitumor immunity. OncoImmunology, 4 (9), e1002721.
   PubMed Web of Science ®Google Scholar
• Bai, Y.P., et al., 2015. FGF-1/-3/FGFR4 signaling in cancer-associated fibroblasts promotes tumor progression in colon cancer through Erk and MMP-7. Cancer science, 106 (10), 1278–1287.
   PubMed Web of Science ®Google Scholar
• Barton, G.M., 2008. A calculated response: control of inflammation by the innate immune system. The journal of clinical investigation, 118 (2), 413–420.
   PubMed Web of Science ®Google Scholar
• Carvalho, T.T., et al., 2015. Granulocyte-colony stimulating factor (G-CSF)-induced mechanical hyperalgesia in mice: role for peripheral TNFα, IL-1β and IL-10. European journal of pharmacology, 749, 62–72.
   PubMed Web of Science ®Google Scholar
• Cheadle, E.J., et al., 2007. Eotaxin-2 and colorectal cancer: a potential target for immune therapy. Clinical cancer research: an official journal of the American association for cancer research, 13 (19), 5719–5728.
   PubMed Web of Science ®Google Scholar
• Daghestani, M., et al., 2019. The anti-cancer effects of Echis coloratus and Walterinnesia aegyptia venoms on colon cancer cells. Toxin reviews, 1–10. doi:1080/15569543.2018.1564774.
   Web of Science ®Google Scholar
• Delafontaine, M., et al., 2017. Enzymatic and pro-inflammatory activities of bothrops lanceolatus venom: ReleOTvance for envenomation. Toxins, 9 (8), 244.
   Web of Science ®Google Scholar
• Gao, J., et al., 2015. Mechanism of action of IL-7 and its potential applications and limitations in cancer immunotherapy. International journal of molecular sciences, 16 (5), 10267–10280.
   PubMed Web of Science ®Google Scholar
• Hurgin, V., et al., 2007. Antiviral and immunoregulatory activities of IFN-gamma depend on constitutively expressed IL-1alpha. Proceedings of the national academy of sciences of the United States of America, 104 (12), 5044–5049.
   PubMed Web of Science ®Google Scholar
• Itatani, Y., et al., 2016. The role of chemokines in promoting colorectal cancer invasion/metastasis. International journal of molecular sciences, 17 (5), 643.
   Web of Science ®Google Scholar
• Jacobs, J., et al., 2015. Immune checkpoint modulation in colorectal cancer: what’s new and what to expect. Journal of immunology research, 2015, 1–16.
   Web of Science ®Google Scholar
• Janakiram, N.B., and Rao, C.V., 2014. The role of inflammation in colon cancer. Advances in experimental medicine and biology, 816, 25–52.
   PubMed Web of Science ®Google Scholar
• Keum, N., and Giovannucci, E., 2019. Global burden of colorectal cancer: emerging trends, risk factors and prevention strategies. Nature reviews gastroenterology & hepatology, 16 (12), 713–732.
   PubMed Web of Science ®Google Scholar
• Kotredes, K.P., and Gamero, A.M., 2013. Interferons as inducers of apoptosis in malignant cells. Journal of interferon & cytokine research: the official journal of the international society for interferon and cytokine research, 33 (4), 162–170.
   PubMed Web of Science ®Google Scholar
• Litmanovich, A., et al., 2018. The role of interleukin-1 in the pathogenesis of cancer and its potential as a therapeutic target in clinical practice. Oncology and therapy, 6 (2), 109–127.
   PubMed Web of Science ®Google Scholar
• Long, A.G., Lundsmith, E.T., and Hamilton, K.E., 2017. Inflammation and colorectal cancer. Current colorectal cancer reports, 13 (4), 341–351.
   PubMed Web of Science ®Google Scholar
• Mager, L.F., et al., 2016. Cytokine-induced modulation of colorectal cancer. Frontiers in oncology., 6 (96), 1–19.
   PubMedGoogle Scholar
• McConnell, B.B., and Yang, V.W., 2009. The role of inflammation in the pathogenesis of colorectal cancer. Current colorectal cancer reports, 5 (2), 69–74.
   PubMedGoogle Scholar
• Mihalache, A., and Rogoveanu, I., 2014. Angiogenesis factors involved in the pathogenesis of colorectal cancer. Current health sciences journal, 40 (1), 5–11.
   PubMedGoogle Scholar
• Mlecnik, B., 2014. Functional network pipeline reveals genetic determinants associated with in situ lymphocyte proliferation and survival of cancer patients. Science translational medicine, 6 (228), 228–237.
   Web of Science ®Google Scholar
• Morris, K.T., et al., 2014. G-CSF and G-CSFR are highly expressed in human gastric and colon cancers and promote carcinoma cell proliferation and migration. British journal of cancer, 110 (5), 1211–1220.
   PubMed Web of Science ®Google Scholar
• Phinney, B.B., et al., 2018. MK2 regulates macrophage chemokine activity and recruitment to promote colon tumor growth. Frontiers in immunology, 9 (1857), 1857–1812.
   PubMedGoogle Scholar
• Place, D.E., and Kanneganti, T.D., 2019. Cell death-mediated cytokine release and its therapeutic implications. The journal of experimental medicine, 216 (7), 1474–1486.
   PubMed Web of Science ®Google Scholar
• Rawla, P., Sunkara, T., and Barsouk, A., 2019. Epidemiology of colorectal cancer: incidence, mortality, survival, and risk factors. Przeglad gastroenterologiczny, 14 (2), 89–103.
   PubMed Web of Science ®Google Scholar
• Salazar, E., et al., 2019. Contribution of endothelial cell and macrophage activation in the alterations induced by the venom of Micrurus tener tener in C57BL/6 mice. Molecular immunology, 116, 45–55.
   PubMed Web of Science ®Google Scholar
• Sara, P., et al., 2020. Chemokines—what is their role in colorectal cancer? Cancer control, 27 (1), 1–8.
   Web of Science ®Google Scholar
• Schirrrmacher, V., 2019. From chemotherapy to biological therapy: a review of novel concepts to reduce the side effects of systemic cancer treatment. International journal of oncology, 54 (2), 407–419.
   PubMed Web of Science ®Google Scholar
• Stanilov, N., et al., 2010. Advanced colorectal cancer is associated with enhanced IL-23 and IL-10 serum levels. Laboratory medicine, 41 (3), 159–163.
   Google Scholar
• Szondy, Z., et al., 2017. Anti-inflammatory mechanisms triggered by apoptotic cells during their clearance. Frontiers in ImCheamunology, 8, 1–10.
   PubMed Web of Science ®Google Scholar
• Tang, L., et al., 2007. Gene therapy with CX3CL1/Fractalkine induces antitumor immunity to regress effectively mouse hepatocellular carcinoma. Gene therapy, 14 (16), 1226–1234.
   PubMed Web of Science ®Google Scholar
• Tu, S., et al., 2008. Overexpression of interleukin-1beta induces gastric inflammation and cancer and mobilizes myeloid-derived suppressor cells in mice. Cancer cell, 14 (5), 408–419.
   PubMed Web of Science ®Google Scholar
• Voronov, E., and Apte, R.N., 2015. IL-1 in colon inflammation, colon carcinogenesis and invasiveness of colon cancer. Cancer microenvironment: official journal of the international cancer microenvironment society, 8 (3), 187–200.
   PubMed Web of Science ®Google Scholar
• Voronov, E., et al., 1999. The systemic inflammatory response syndrome related to the release of cytokines following sever envenomation. Journal of venomous animals and toxins, 5 (1), 5–33.
   Google Scholar
• Voronov,  ., et al., 2014. The role IL-1 in tumor-mediated angiogenesis. Frontiers in physiology. 5, 114.
   PubMed Web of Science ®Google Scholar
• Wang, D., et al., 2009. The role of chemokines in intestinal inflammation and cancer. Current opinion in pharmacology, 9 (6), 688–696.
   PubMed Web of Science ®Google Scholar
• Wang, J., et al., 2019. IL-9 exerts antitumor effects in colon cancer and transforms the tumor microenvironment in vivo. Technology in cancer research & treatment, 18, 1533033819857737.
   Web of Science ®Google Scholar
• Yacoub, T., et al., 2018. Montivipera bornmuelleri venom has immunomodulatory effects mainly up-regulating pro-inflammatory cytokines in the spleens of mice. Toxicology reports, 5, 318–323.
   PubMed Web of Science ®Google Scholar
• Zaidi, M.R., 2019. The interferon-gamma paradox in cancer. Journal of interferon & cytokine research: the official journal of the international society for interferon and cytokine research, 39 (1), 30–38.
   PubMed Web of Science ®Google Scholar